These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 20847658

  • 1. Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%.
    Malta JB, Soong HK, Shtein RM, Musch DC, Rhoades W, Sugar A, Mian SI.
    Cornea; 2010 Dec; 29(12):1392-6. PubMed ID: 20847658
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease.
    Rao SN, Rao RD.
    Cornea; 2006 Jul; 25(6):674-8. PubMed ID: 17077659
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [A 0,05% cyclosporine treatment of the advanced dry eye syndrome].
    Kujawa A, Rózycki R.
    Klin Oczna; 2005 Jul; 107(4-6):280-6. PubMed ID: 16118939
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy.
    Su MY, Perry HD, Barsam A, Perry AR, Donnenfeld ED, Wittpenn JR, D'Aversa G.
    Cornea; 2011 Oct; 30(10):1098-104. PubMed ID: 21407074
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.
    Wilson SE, Perry HD.
    Ophthalmology; 2007 Jan; 114(1):76-9. PubMed ID: 17070588
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of topical cyclosporine for the treatment of dry eye disease.
    Perry HD, Solomon R, Donnenfeld ED, Perry AR, Wittpenn JR, Greenman HE, Savage HE.
    Arch Ophthalmol; 2008 Aug; 126(8):1046-50. PubMed ID: 18695097
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of topical cyclosporine A on clinical findings and cytological grade of the disease in patients with dry eye.
    Sahli E, Hoşal BM, Zilelioğlu G, Gülbahçe R, Ustün H.
    Cornea; 2010 Dec; 29(12):1412-6. PubMed ID: 20847673
    [Abstract] [Full Text] [Related]

  • 13. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
    Demiryay E, Yaylali V, Cetin EN, Yildirim C.
    Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Corneal complications after hematopoietic stem cell transplantation].
    Mittelviefhaus H, Auw-Hädrich C.
    Ophthalmologe; 2003 Mar; 100(3):222-9. PubMed ID: 12640552
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
    Lanino E, Rondelli R, Locatelli F, Messina C, Pession A, Balduzzi A, Favre C, Santarone S, Rabusin M, Pollichieni S, Cesaro S, Dini G, Franca Fagioli for the AIEOP-HSCT Group.
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):741-8. PubMed ID: 19450759
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.